REFERENCES
- Newman S. P., Clarke S. W. Therapeutical Aerosols. I. Physical and Practical Considerations. Thorax 1983; 38(12)881–886
- Gonda I., Byron P. R. Perspectives on the Biopharmacy of Inhalation of Aerosols. Drug Dev. Ind. Pharm. 1978; 4: 243–259
- Webb J., Rees J., Clark T. A Comparison of the Effects of Different Methods of Administration of beta-Sympathomimetics in Patients with Asthma. Br J. Dis. Chest 1982; 76(4)351–357
- Vidgren M. T., Kärkkäinen A., Paronen T. P., Karjalainen P. Respiratory Tract Deposition of 99mTc-Labeled Drug Particles Administered via a Dry Powder Inhaler. Int. J. Pharm. 1987; 39: 101–105
- Arppe J., Vidgren M. Practical Gamma Labeling Method for Metered Dose Inhalers and Inhalation Powders. STP Pharma Sci. 1994; 4(1)19–22
- Newman S. P. Scintigraphic Assessment of Therapeutic Aerosols. Crit. Rev. Ther. Carrier Syst. 1993; 10(1)65–109
- Tomkiewicz R. P., App E. M., Coffiner M., Fossion J., Maes P., King M. Mucolytic Treatment of N-Acetylcysteine l-Lysinate Metered-Dose Inhaler in Dogs: Airway Epithelial Function Changes. Eur. Resp. J. 1994; 7: 81–87
- Vanderbist F., Maes P., Neve J. In Vitro Comparative Assessment of Antioxidant Activity of Nacystelyn Against Three Reactive Oxygen Species. Arzneimittel Forschung (Drug Res) 1996; 8(46 (II))783–788
- Nagy A. M., Vanderbist F., Parij N., Maes P., Fondu P., Neve J. Effect of the Mucoactive Drug Nacystelyn on the Respiratory Burst of Human Blood Polymorphonuclear Neutrophils. Pulmonary Pharmacol. 1997; 10: 287–292
- Tomkiewicz R. P., App E. M., De Sanctis G. T., Coffiner M., Maes P., Rubin P., King M. A Comparison of a New Mucolytic N-Acetylcysteine l-Lysinate with N-Acetylcysteine: Airway Epithelial Function and Mucus Changes in Dog. Pulmonary Pharmacol. 1996; 8: 259–265
- Hardy J. G., Everard M. L., Coffiner M., Fossion J. Lung Deposition of a Nacystelyn Metered-Dose Inhaler Formulation. J. Aerosol Med. 1993; 6: 37–44
- Daly J. J. Replacements for CFC Propellants: A Technical and Environmental Overview. J. Biopharm. Sci. 1992; 3: 265
- Borgstrom L., Newman S. P., Weisz A., Moren F. Pulmonary Deposition of Inhaled Terbutaline: Comparison of Scanning Gamma Camera and Urinary Excretion Methods. J. Phar. Sci. 1992; 81: 753–755
- Devadason S. G., Everard M. L., MacEarlan C., Roller C., Summers Q. A., Swift P., Borgstrom L., Le Souëf P. N. Lung Deposition from the Turbuhaler in Children with Cystic Fibrosis. Eur. Respir. J. 1997; 10: 2023–2028
- Agnew J. E., Francis R. A., Pavia D., Clark S. W. Quantitative Comparison of 99mTc Aerosol and 81Krm Ventilation Images. Clin. Phys. Physiol. Measures 1982; 3: 21–30
- Newman S. P., Clark A. R., Talaee N., Clarke S. W. Pressurised Aerosol Deposition in the Human Lung with and without an Open Spacer Device. Thorax 1982; 44: 706–710
- O'Doherty M. J., Thomas S. H.L., Gibb D., et al. Lung Deposition of Nebulised Pentamidine in Children. Thorax 1993; 48: 220–226